1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Baker Bros. Advisors Lp Buys Achaogen, BeiGene, Advanced Accelerator Applications SA, Sells AbbVie, Exelixis, TG Therapeutics

New York, NY, based Investment company Baker Bros. Advisors Lp buys Achaogen, BeiGene, Advanced Accelerator Applications SA, AveXis, Abeona Therapeutics, NeuroDerm, Ascendis Pharma A/S, Rigel Pharmaceuticals, Aevi Genomic Medicine, Idera Pharmaceuticals, sells AbbVie, Exelixis, TG Therapeutics, Vitae Pharmaceuticals, Arrowhead Pharmaceuticals during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Baker Bros. Advisors Lp. As of 2016-12-31, Baker Bros. Advisors Lp owns 124 stocks with a total value of $9 billion. These are the details of the buys and sells.

For the details of BAKER BROS. ADVISORS LP's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=BAKER+BROS.+ADVISORS+LP

These are the top 5 holdings of BAKER BROS. ADVISORS LP
  1. Seattle Genetics Inc (SGEN) - 45,711,856 shares, 26.92% of the total portfolio. Shares added by 3.65%
  2. Incyte Corp (INCY) - 23,499,087 shares, 26.29% of the total portfolio.
  3. Alexion Pharmaceuticals Inc (ALXN) - 6,543,295 shares, 8.93% of the total portfolio.
  4. ACADIA Pharmaceuticals Inc (ACAD) - 25,819,768 shares, 8.31% of the total portfolio.
  5. Genomic Health Inc (GHDX) - 13,770,302 shares, 4.52% of the total portfolio.
New Purchase: AveXis Inc (AVXS)

Baker Bros. Advisors Lp initiated holdings in AveXis Inc. The purchase prices were between $42 and $71.36, with an estimated average price of $53.44. The stock is now traded at around $57.97. The impact to the portfolio due to this purchase was 0.17%. The holdings were 315,300 shares as of 2016-12-31.

New Purchase: Biogen Inc (BIIB)

Baker Bros. Advisors Lp initiated holdings in Biogen Inc. The purchase prices were between $251.91 and $298.81, with an estimated average price of $273.04. The stock is now traded at around $289.89. The impact to the portfolio due to this purchase was 0.05%. The holdings were 16,500 shares as of 2016-12-31.

New Purchase: Aevi Genomic Medicine Inc (GNMX)

Baker Bros. Advisors Lp initiated holdings in Aevi Genomic Medicine Inc. The purchase prices were between $4.2 and $6.85, with an estimated average price of $5.26. The stock is now traded at around $4.96. The impact to the portfolio due to this purchase was 0.05%. The holdings were 880,539 shares as of 2016-12-31.

New Purchase: Rigel Pharmaceuticals Inc (RIGL)

Baker Bros. Advisors Lp initiated holdings in Rigel Pharmaceuticals Inc. The purchase prices were between $2.38 and $4.01, with an estimated average price of $2.86. The stock is now traded at around $2.36. The impact to the portfolio due to this purchase was 0.05%. The holdings were 2,018,882 shares as of 2016-12-31.

New Purchase: Ra Pharmaceuticals Inc (RARX)

Baker Bros. Advisors Lp initiated holdings in Ra Pharmaceuticals Inc. The purchase prices were between $12.74 and $16.14, with an estimated average price of $13.59. The stock is now traded at around $22.34. The impact to the portfolio due to this purchase was 0.03%. The holdings were 177,952 shares as of 2016-12-31.

New Purchase: Spring Bank Pharmaceuticals Inc (SBPH)

Baker Bros. Advisors Lp initiated holdings in Spring Bank Pharmaceuticals Inc. The purchase prices were between $7.42 and $11.96, with an estimated average price of $9.16. The stock is now traded at around $7.86. The impact to the portfolio due to this purchase was 0.02%. The holdings were 219,298 shares as of 2016-12-31.

Added: Achaogen Inc (AKAO)

Baker Bros. Advisors Lp added to the holdings in Achaogen Inc by 4482.38%. The purchase prices were between $3.77 and $14.86, with an estimated average price of $6.86. The stock is now traded at around $20.95. The impact to the portfolio due to this purchase was 0.66%. The holdings were 4,582,382 shares as of 2016-12-31.

Added: BeiGene Ltd (BGNE)

Baker Bros. Advisors Lp added to the holdings in BeiGene Ltd by 92.04%. The purchase prices were between $26.95 and $36.9, with an estimated average price of $31.43. The stock is now traded at around $40.19. The impact to the portfolio due to this purchase was 0.59%. The holdings were 3,673,175 shares as of 2016-12-31.

Added: Advanced Accelerator Applications SA (AAAP)

Baker Bros. Advisors Lp added to the holdings in Advanced Accelerator Applications SA by 110.56%. The purchase prices were between $23.71 and $38.96, with an estimated average price of $33.62. The stock is now traded at around $35.90. The impact to the portfolio due to this purchase was 0.34%. The holdings were 2,167,137 shares as of 2016-12-31.

Added: Abeona Therapeutics Inc (ABEO)

Baker Bros. Advisors Lp added to the holdings in Abeona Therapeutics Inc by 1556.53%. The purchase prices were between $4.25 and $8.7, with an estimated average price of $6.26. The stock is now traded at around $5.93. The impact to the portfolio due to this purchase was 0.08%. The holdings were 1,684,364 shares as of 2016-12-31.

Added: NeuroDerm Ltd (NDRM)

Baker Bros. Advisors Lp added to the holdings in NeuroDerm Ltd by 87.43%. The purchase prices were between $15.55 and $23.1, with an estimated average price of $18.71. The stock is now traded at around $24.20. The impact to the portfolio due to this purchase was 0.07%. The holdings were 571,667 shares as of 2016-12-31.

Added: Ascendis Pharma A/S (ASND)

Baker Bros. Advisors Lp added to the holdings in Ascendis Pharma A/S by 37.26%. The purchase prices were between $18.86 and $21.08, with an estimated average price of $19.97. The stock is now traded at around $27.59. The impact to the portfolio due to this purchase was 0.06%. The holdings were 1,023,266 shares as of 2016-12-31.

Sold Out: TG Therapeutics Inc (TGTX)

Baker Bros. Advisors Lp sold out the holdings in TG Therapeutics Inc. The sale prices were between $4.65 and $9.33, with an estimated average price of $5.86.

Sold Out: Arrowhead Pharmaceuticals Inc (ARWR)

Baker Bros. Advisors Lp sold out the holdings in Arrowhead Pharmaceuticals Inc. The sale prices were between $1.24 and $7.52, with an estimated average price of $4.26.

Sold Out: Vitae Pharmaceuticals Inc (VTAE)

Baker Bros. Advisors Lp sold out the holdings in Vitae Pharmaceuticals Inc. The sale prices were between $20.94 and $21, with an estimated average price of $20.98.

Sold Out: Endocyte Inc (ECYT)

Baker Bros. Advisors Lp sold out the holdings in Endocyte Inc. The sale prices were between $2.55 and $3.39, with an estimated average price of $2.87.

Sold Out: Ophthotech Corp (OPHT)

Baker Bros. Advisors Lp sold out the holdings in Ophthotech Corp. The sale prices were between $4.82 and $45.3, with an estimated average price of $29.68.

Sold Out: Mast Therapeutics Inc (MSTX)

Baker Bros. Advisors Lp sold out the holdings in Mast Therapeutics Inc. The sale prices were between $0.07 and $0.12, with an estimated average price of $0.09.

Reduced: AbbVie Inc (ABBV)

Baker Bros. Advisors Lp reduced to the holdings in AbbVie Inc by 88.25%. The sale prices were between $55.78 and $64, with an estimated average price of $61.04. The stock is now traded at around $61.23. The impact to the portfolio due to this sale was -8.22%. Baker Bros. Advisors Lp still held 1,685,994 shares as of 2016-12-31.

Reduced: Exelixis Inc (EXEL)

Baker Bros. Advisors Lp reduced to the holdings in Exelixis Inc by 39.07%. The sale prices were between $10.2 and $18.25, with an estimated average price of $14.43. The stock is now traded at around $22.41. The impact to the portfolio due to this sale was -0.25%. Baker Bros. Advisors Lp still held 3,003,569 shares as of 2016-12-31.



Here is the complete portfolio of BAKER BROS. ADVISORS LP. Also check out:

1. BAKER BROS. ADVISORS LP's Undervalued Stocks
2. BAKER BROS. ADVISORS LP's Top Growth Companies, and
3. BAKER BROS. ADVISORS LP's High Yield stocks
4. Stocks that BAKER BROS. ADVISORS LP keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


JFranklinearn accel ps stage 2
jan.ellsbergerHernhag rev5
jan.ellsbergerHernhag rev4
jan.ellsbergerHernhag rev3
jan.ellsbergerHernhag rev2
jan.ellsbergerHernhag
BoubaPFS Value Sector
18th_bronzemanzz_ultra_alpha_w_div_conservat
eae010Forward Growth Edited
bpatton23L/Cap value
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK